Akorn Appoints Greg Lawless as Chief Human Resources Officer

LAKE FOREST, Ill., Jan. 21, 2016 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P. Lawless joined Akorn as Chief Human Resources Officer on January 18, 2016.

Mr. Lawless joins Akorn from The Kraft Heinz Company, where he served most recently as Vice President, Human Resources over his 13 years at the company. In his most recent role at Kraft Heinz, Mr. Lawless was responsible for human resources needs for the company’s Global Operations organization. Mr. Lawless began his distinguished career in human resources at Philip Morris USA. Mr. Lawless holds a B.A. in Economics and Government from Colby College.

“Greg is an accomplished executive with over 25 years of experience in human resources at Fortune 500 companies and we are pleased to bring his skills and background to Akorn to lead our global HR team,” said Raj Rai, Akorn’s Chief Executive Officer. “I look forward to Greg’s leadership and contributions to support our global workforce and growth initiatives.”

About Akorn

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois; Somerset, New Jersey; Amityville, New York; Hettlingen, Switzerland and Paonta Sahib, India where the Company manufactures ophthalmic, injectable and specialty sterile and non-sterile pharmaceuticals. Additional information is available on the Company's website at www.akorn.com.

Forward Looking Statements

This press release includes statements that may constitute "forward looking statements", including the expected timing of filings, the timing and successful implementation of remediation efforts, the expected impact of the restatement on our financial results, the expected timeline and results of investigations, the results of Nasdaq hearings and determinations and other statements regarding Akorn's regulatory approvals, goals and strategy. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Factors that could cause or contribute to such differences include, but are not limited to: the difficulty of predicting the timing of the completion of our restatement, its impact on our financial results, and the timing of the related filings; costs, risks, and uncertainties associated with pending investigation matters described herein; changes in the laws and regulations and such other risks and uncertainties outlined in Akorn's periodic public filings with the SEC and in other written or oral investor communications. Other factors besides those listed there could also adversely affect our results. Except as expressly required by law, Akorn disclaims any intent or obligation to update these forward-looking statements.

Investors/Media:
Dewey Steadman
Executive Director, Investor Relations
(847) 582-6923
[email protected]